Related Experiment Video
Updated: Jul 4, 2025
03:51
Author Spotlight: Advanced Treatment of Seminal Duct Blockage Employing Endoscopy-Mediated Semen Channel Refluviation
Published on: December 8, 2023
2.7K
Treatment Options for Male Hypogonadism.
1Professional Compounding Centers of America, Houston, Texas. bbiundo@pccarx.com.
International Journal of Pharmaceutical Compounding
|February 2, 2024
Summary
Male hypogonadism, linked to aging, affects many men. Pharmacists play a key role in diagnosing and treating low testosterone (hypogonadism) with various methods and managing patient expectations.
Area of Science:
- Endocrinology
- Men's Health
- Pharmacology
Background:
- Male hypogonadism is a prevalent condition often associated with aging.
- Growing research continually enhances our understanding of hypogonadism.
- Pharmacists are uniquely positioned to aid in the diagnosis and management of hypogonadal men.
Purpose of the Study:
- To discuss methods for restoring testosterone levels in men.
- To outline the varying expectations associated with different testosterone restoration treatments.
- To highlight the pharmacist's role in optimizing hypogonadism care.
Main Methods:
- Review of current testosterone restoration therapies.
- Discussion of diagnostic approaches for male hypogonadism.
- Analysis of patient expectations and treatment outcomes.
Main Results:
- Multiple therapeutic options exist for testosterone replacement.
- Treatment efficacy and patient expectations can vary significantly.
- Pharmacist involvement can improve patient outcomes and treatment adherence.
Conclusions:
- Effective management of male hypogonadism requires a comprehensive approach.
- Pharmacists are integral to patient education, treatment monitoring, and achieving therapeutic goals.
- Understanding treatment expectations is crucial for successful testosterone restoration therapy.
Related Concept Videos
01:23Infertility in Males
264
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
264
01:20Disorders of the Male Reproductive System
419
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
419
01:26Testosterone: Functions and Regulation
669
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
669
01:41Spermatogenesis
102.5K
Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male...
102.5K
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
158
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
158
01:17Male Sexual Response: Erection & Ejaculation
2.3K
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
2.3K